Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 37K
2: EX-99.1 Miscellaneous Exhibit HTML 63K
3: EX-99.2 Miscellaneous Exhibit HTML 896K
4: EX-99.3 Miscellaneous Exhibit HTML 10K
9: R1 Cover HTML 57K
11: XML IDEA XML File -- Filing Summary XML 12K
14: XML XBRL Instance -- jnj-20240416_htm XML 25K
10: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
6: EX-101.DEF XBRL Definitions -- jnj-20240416_def XML 43K
7: EX-101.LAB XBRL Labels -- jnj-20240416_lab XML 86K
8: EX-101.PRE XBRL Presentations -- jnj-20240416_pre XML 44K
5: EX-101.SCH XBRL Schema -- jnj-20240416 XSD 14K
12: JSON XBRL Instance as JSON Data -- MetaLinks 15± 21K
13: ZIP XBRL Zipped Folder -- 0000200406-24-000031-xbrl Zip 68K
iOne Johnson & Johnson Plaza, iNew Brunswick, iNew
Jerseyi08933
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
i732-i524-0400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, Par Value $1.00
iJNJ
iNew York Stock Exchange
i0.650% Notes Due May 2024
iJNJ24C
iNew
York Stock Exchange
i5.50% Notes Due November 2024
iJNJ24BP
iNew York Stock Exchange
i1.150%
Notes Due November 2028
iJNJ28
iNew York Stock Exchange
i1.650% Notes Due May 2035
iJNJ35
iNew
York Stock Exchange
Item 2.02 Results of Operations and Financial Condition
On April 16, 2024, Johnson & Johnson issued the attached press release (Exhibit 99.3) announcing that its Board of Directors declared a 4.2% increase in the quarterly dividend rate, from $1.19 to $1.24 per share, marking the 62nd year of
consecutive increases. At the new rate, the indicated dividend on an annual basis is $4.96 per share compared to the previous rate of $4.76 per share. The next quarterly dividend is payable on June 4, 2024 to shareholders of record as of the close of business on May 21, 2024. The ex-dividend date is May
20, 2024.
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.